Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorder

INTRODUCTION: Individuals with idiopathic rapid eye movement sleep behavior disorder (iRBD) are at high risk for a clinical diagnosis of an α‐synucleinopathy (aSN). They could serve as a key population for disease‐modifying trials. Abnormal dopamine transporter (DAT) imaging is a strong candidate bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chahine, Lana M., Brumm, Michael C., Caspell‐Garcia, Chelsea, Oertel, Wolfgang, Mollenhauer, Brit, Amara, Amy, Fernandez‐Arcos, Ana, Tolosa, Eduardo, Simonet, Cristina, Hogl, Birgit, Videnovic, Aleksandar, Hutten, Samantha J., Tanner, Caroline, Weintraub, Daniel, Burghardt, Elliot, Coffey, Christopher, Cho, Hyunkeun R., Kieburtz, Karl, Poston, Kathleen L., Merchant, Kalpana, Galasko, Douglas, Foroud, Tatiana, Siderowf, Andrew, Marek, Kenneth, Simuni, Tanya, Iranzo, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818144/
https://www.ncbi.nlm.nih.gov/pubmed/33321002
http://dx.doi.org/10.1002/acn3.51269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818144/
https://www.ncbi.nlm.nih.gov/pubmed/33321002
http://dx.doi.org/10.1002/acn3.51269

Ejemplares similares